HIGHLIGHTS
- who: Guangchuan Deng et al. from the Xiangya Hospital, Central South University, China have published the research: Effect of EGFR-TKIs combined with craniocerebral radiotherapy on the prognosis of EGFR-mutant lung adenocarcinoma patients with brain metastasis: A propensity-score matched analysis, in the Journal: (JOURNAL)
- what: The study was approved by the Ethics Committee of Shandong Cancer Hospital and Institute and was conducted in accordance with the Declaration of Helsinki. Subsequently, the relevant experiments were designed to provide theoretical support that EGFR-TKIs combined with craniocerebral radiotherapy is a superior treatment option, as compared . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.